IntegraGen Genomics offers access to the latest innovative technologies in molecular biology enabling you to implement your genomic research projects and also develops partnerships and collaborations with leading academic and industrial researchers.

The SeqOIA Cooperative Health Group selects IntegraGen as the operator of its sequencing platform as part of the France Genomic Medicine 2025 Plan

IntegraGen has announced that it has been selected by the Sequencing Omics Information Analysis (SeqOIA) Cooperative Health Group (GCS) for the operation of its high throughput sequencing platform. The SeqOIA GCS, which includes the Assistance Publique- Hôpitaux de Paris, the Institut Curie and the Gustave Roussy Cancer Center, (…)  » 

IntegraGen and Twist Bioscience Expand Partnership with Distribution Agreement for SIRIUS and MERCURY Genomic Data Analysis Tools

IntegraGen announces a global distribution agreement with Twist Bioscience for IntegraGen’s portfolio of genomic data analysis tools. The agreement includes distribution rights for SIRIUS™, an online Big Data solution that assists researchers to quickly and intuitively analyze exome data for Mendelian and oncology applications, and MERCURY™, an online (…)  » 

IntegraGen Partners with Twist Bioscience

IntegraGen today announced the addition of Twist Bioscience Corporation’s Human Core Exome Complete Kit, a streamlined library prep and exome enrichment solution, to its next-generation targeted sequencing product offerings. Under the terms of the agreement Twist Bioscience will provide IntegraGen its Human Core Exome Complete Kit for all target (…)  »